XLRN stock news

Acceleron (XLRN) delivered earnings and revenue surprises of -41.67% and 1.95%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock? Read more
XLRN earnings call for the period ending March 31, 2019. Read more
Acceleron Pharma, Inc. (NASDAQ:XLRN) Q1 2019 Earnings Conference Call May 9, 2019, 5:00 pm ET Company Participants Todd James - VP, IR & Corporate Communica Read more
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news. Read more
Both Alder BioPharmaceuticals Inc. (NASDAQ:ALDR) and Acceleron Pharma Inc. (NASDAQ:XLRN) are each other’s competitor in the Biotechnology industry. Thus the contrast of their risk, analyst recommend Read more
We will be comparing the differences between Acceleron Pharma Inc. (NASDAQ:XLRN) and Protagonist Therapeutics Inc. (NASDAQ:PTGX) as far as analyst Read more

Proudly made at